FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > FSD Pharma made the right moves

<< Previous

Bullboard Posts

Next >>

Comment by Renofundon Oct 25, 2021 5:25pm

51 Views

Post# 34047196

RE:FSD Pharma made the right moves

DavidRosenberg wrote: With their lucid acquisition only time will tell the yielded results if the trials but they have solid scientists at UHN

$TRIL buyout was excellent by Pfizer they were also part of UHN commercialization network

let's see how the molecules come around once they start trials and IND Phase 1 cheers

classic Rosie. Skirts any questions that involve facts, and compares to other companies. Wash, rinse, repeat. What chapter of your handbook lays out that strategy? Had his wrist slapped on CEO.ca, stockhouse is a little more wild west

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth